Abstract
The goal of the study was to assess the efficacy of the enhanced external counterpulsation (EECP) therapy in patients with symptomatic stable coronary artery disease (CAD) and severe obstructive sleep apnea (OSA). Open-label, non-controlled clinical study. Forty five (n=45) stable symptomatic CAD
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
